Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000947871-24-000909
Filing Date
2024-11-14
Accepted
2024-11-14 18:23:00
Documents
1
Group Members
ORBIMED CAPITAL GP IX LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ss4113290_sc13g.htm SC 13G 67279
  Complete submission text file 0000947871-24-000909.txt   68979
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

EIN.: 133976876 | State of Incorp.: DE
Type: SC 13G

Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Subject) CIK: 0001534120 (see all company filings)

EIN.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89290 | Film No.: 241464970
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)